Marburg hemorrhagic fever differential diagnosis: Difference between revisions
Aditya Ganti (talk | contribs) |
No edit summary |
||
Line 22: | Line 22: | ||
{| class="wikitable" | {| class="wikitable" | ||
! rowspan="3" | | ! rowspan="3" |Virus | ||
! rowspan="3" | | ! rowspan="3" |Disease | ||
! rowspan="3" |Incubation | ! rowspan="3" |Incubation | ||
Revision as of 16:46, 20 October 2017
Marburg hemorrhagic fever Microchapters |
Differentiating Marburg hemorrhagic fever from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Marburg hemorrhagic fever differential diagnosis On the Web |
American Roentgen Ray Society Images of Marburg hemorrhagic fever differential diagnosis |
Marburg hemorrhagic fever differential diagnosis in the news |
Risk calculators and risk factors for Marburg hemorrhagic fever differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief:
Overview
Differentiating Marburg Hemorrhagic Fever from other Diseases
Marburg hemorrhagic fever must be differentiated from other diseases that may cause fever, abdominal pain, diarrhea, vomiting and bleeding such as:
- Malaria
- Typhoid fever
- Shigellosis
- Cholera
- Leptospirosis
- Plague,
- Rickettsiosis
- Relapsing fever
- Meningitis
- Hepatitis
- Other viral hemorrhagic fevers
Virus | Disease | Incubation
Period |
Symptoms | Laboratory
findings | |||||
---|---|---|---|---|---|---|---|---|---|
Prodromal phase | Illness phase | ||||||||
Fever | Headache | Myalgia | Abdominal pain | Hemorrhage | |||||
Filoviruses | Marburg Hemorrhagic Fever | 5-10 | + | + | + | + | + |
|
|
Ebola | 2-21 | + | + | + | + | + | |||
Bunyaviruses | Crimean-Congo hemorrhagic fever (CCHF) | 13 | + | + | + | + | + |
|
|
Hantavirus Infection | 9 -33 | + | + | + | - | + |
|
||
Rift Valley fever | 2-6 | + | - | + | - | - |
|
||
Arenaviruses | Lassa fever | 7-21 | + | + | + | - | - |
|
|
Lujo hemorrhagic fever | 7-13 |
|
|||||||
Lymphocytic choriomeningitis (LCM) | 8-13 | + | + | + | - | - |
|
||
Flaviviruses | Alkhurma hemorrhagic fever (AFD) | 2-4 | + | - | + | - | - |
|
|
Kyasanur Forest Disease (KFD) | 3-8 | + | + | + | + | + | Biphasic
|
| |
Omsk hemorrhagic fever | 3-8 | + | + | + | + | + | Biphasic
|
|
Treatment should be based on the most likely etiology of fever according to local epidemiology. If the fever continues after 3 days of recommended treatment, and if the patient has signs such as bleeding or shock, a viral hemorrhagic fever should be considered. It is important to review the patient’s history for any contact with someone who was ill with fever and bleeding or who died from an unexplained illness with fever and bleeding.
Shown below is a table summarizing the typical findings of the differential diagnoses of MHF.
Disease | Findings |
---|---|
Shigellosis & other bacterial enteric infections | Presents with diarrhea, possibly bloody, accompanied by fever, nausea, and sometimes toxemia, vomiting, cramps, and tenesmus. Stools contain blood and mucous in a typical case. A search for possible sites of bacterial infection, together with cultures and blood smears, should be made. Presence of leucocytosis distinguishes bacterial infections. |
Typhoid fever | Presents with fever, headache, rash, gastrointestinal symptoms, with lymphadenopathy, relative bradycardia, cough and leucopenia and sometimes sore throat. Blood and stool culture can demonstrate causative bacteria. |
Malaria | Presents with acute fever, headache and sometime diarrhea (children). Blood smears must be examined for malaria parasites. Presence of parasites does not exclude concurrent viral infection. Antimalarial must be prescribed in an attempt at therapy. |
Lassa fever | Disease onset is usually gradual, with fever, sore throat, cough, pharyngitis, and facial edema in the later stages. Inflammation and exudation of the pharynx and conjunctiva are common. |
Yellow fever and other Flaviviridae | Present with hemorrhagic complications. Epidemiological investigation may reveal a pattern of disease transmission by an insect vector. Virus isolation and serological investigation serves to distinguish these virus. Confirmed history of previous yellow fever vaccination will rule out yellow fever. |
Others | Viral hepatitis, leptospirosis, rheumatic fever, typhus, and mononucleosis produce signs and symptoms that may be confused with Ebola in the early stages of infection. |
Table adapted from WHO Guidelines For Epidemic Preparedness And Response: Ebola Haemorrhagic Fever [1] |
Disease | Incubation period | Vector | Symptoms | Physical signs | Lab findings | Other findings | Treatment | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Cough | Rash | Joint pain | Myalgia | Diarrhea | Common hemorrhagic symptoms | Characterestic physical finding | Icterus | Plasma Creatine kinase | Confirmatory test | |||||
Leptospirosis | 2 to 30 days | Rodents
Domestic animals |
Fever last for 4-7 days, remission for 1-2 days and then relapse | + | Present over legs Hemorrhagic rash | + | +
(Severe myalgia is characteristic of leptospirosis typically localized to the calf and lumbar areas) |
+ | Conjunctival hemorrhage, | Conjunctival suffusion | + | Elevated | Microscopic agglutination test of urine | History of exposure to soil or water
contaminated by infected rodents Recent history travel to tropical, sub tropical areas or humid areas |
NSAIDs |
Dengue | 4 to 10 days | Aedes mosquito | Fever last for 1-2 days,
remission for 1-2 days and then relapse for 1-2 days (Biphasic fever pattern) |
- | Over legs and trunk
pruritic rash May be hemorrhagic |
+ | + | - | Upper gastrointestinal bleeding | Painful lymphadenopathy | - | Normal | Serology showing positive IgM or IgG | Recent travel to South America, Africa, Southeast Asia | Supportive care
Avoid aspirin and other NSAIDs |
Malaria |
|
Female Anopheles | Fever present daily or on alternate day or every 3 days depending on Plasmodium sps. | - | No rash | - | + | - | Bloody urine | Hepatosplenomegaly | + | Normal | Giemsa stained thick and thin blood smears | Recent travel to South America, Africa, Southeast Asia | Anti malarial regimen |
Ebola | 2 to 21 days. | No vector
Human to human transmission |
+ | + | Maculopapular
non-pruritic rash with erythema Centripetal distribution |
+ | + | +
May be bloody in the early phase |
Epistaxis | Sudden onset of high fever with conjunctival injection and early gastrointestinal symptoms | - | Normal | RT-PCR | Recent visit to endemic area especially African countries | Isolation of the patient,
supportive therapy |
Influenza | 1-4 days | No vector | + | + | +/- | + | + | + | - | Fever and upper respiratory symptoms | - | Normal | Viral culture or PCR | Health care workers
Patients with co-morbid conditions |
Symptomatic treatment |
Yellow fever | 3 to 6 days | Aedes or Haemagogus species mosquitoes | + | + | - | - | + | - | Conjunctival hemorrhage, | Relative bradycardia | + | Normal | RT-PCR, | Recent travel to Africa, South and Central America, and the Caribbean.
Tropical rain forests of south America |
Symptomatic treatment, |
Typhoid fever | 6 to 30 days | No vector | + | - | Blanching erythematous
maculopapularlesions on the lower chest and abdomen |
+ | + | + | Intestinal bleeding | Rose spots | - | Normal | Blood or stool culture showing salmonella typhi sps. | Residence in endemic area
Recent travel to endemic area |
Fluoroquinolones, |